Related Experiment Video
Updated: Jan 3, 2026
12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.9K
Medication management in intellectual disability settings: A systematic review
Fintan Sheerin1, Jessica Eustace-Cook1, Francesca Wuytack1
1University of Dublin, 214057Trinity College Dublin, Ireland.
Journal of Intellectual Disabilities : JOID
|November 19, 2019
Summary
Medication management for people with intellectual disability is complex, with limited evidence and tools available. Further research is needed to develop effective practices and guidelines for this population.
Area of Science:
- Healthcare Management
- Intellectual Disability Services
- Medication Administration
Background:
- High medication usage in intellectual disability populations due to complex health needs.
- Need for effective medication management strategies in these settings.
Purpose of the Study:
- To explore medication management and administration in intellectual disability settings.
- Identify practice frameworks, collaborative practice benefits, key processes, support tools, and outcome metrics.
Main Methods:
- Systematic review of 64 sources.
- Analysis of existing literature on medication management.
Main Results:
- Limited evidence found regarding medication management processes.
- No specific assessment tools identified.
- Adherence and errors noted as potential outcome measures.
Conclusions:
- Paucity of guidelines and frameworks for medication management in intellectual disability settings is a concern.
- Further practice development and research are essential, considering unique challenges.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
189
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
189
01:29Intellectual Disability
557
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
557
01:28Drug Therapy
223
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
223
01:21Factors Affecting Drug Response: Overview
2.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.8K
01:26Psychosis: Goals of Pharmacotherapy
415
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
415
01:22Alzheimer's Disease: Treatment
718
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
718